A rare disease refers to a condition, disorder, or illness that impacts fewer than 200,000 people in the United States. As reported by the National Organization for Rare Disorders, there are more than 10,000 such rare diseases, collectively affecting over 30 million Americans. Over 80% of the rare diseases are said to be genetic in origin.
The stock we are bringing to your attention today is that of Sarepta Therapeutics Inc. (SRPT), which is developing treatments for some of the world's most debilitating, prevalent, and complex rare genetic diseases like Duchenne muscular dystrophy, limb-girdle muscular dystrophies, and Charcot-Marie-Tooth disease.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com